MAPT and Alzheimer disease: In the brains of AD patients, tau becomes hyperphosphorylatedat multiple serine, threonine, and tyrosine residues due to an imbalancein the activities of tau kinases and phosphatases, leading to theformation of insoluble tau aggregates that disrupt neuronal function.8−10